The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Rakhmatulina M.R.

State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Modern trends in the treatment of genital papillomavirus infection

Authors:

Rakhmatulina M.R.

More about the authors

Read: 1639 times


To cite this article:

Rakhmatulina MR. Modern trends in the treatment of genital papillomavirus infection. Russian Journal of Clinical Dermatology and Venereology. 2021;20(3):27‑32. (In Russ.)
https://doi.org/10.17116/klinderma20212003127

Recommended articles:
Modern methods of treatment of latent form of HPV infe­ction: clinical obse­rvation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):425-429

References:

  1. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch, FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007;7(7):453-459.  https://doi.org/10.1016/S1473-3099(07)70158-5
  2. Global health sector strategy on Sexually Transmitted Infections, 2016-2021. Accessed Mar 10, 2021. https://apps.who.int/iris/bitstream/handle/10665/246296/WHO-RHR-16.09-eng.pdf?sequence=1
  3. Clinical guidelines Anogenital (venereal) warts. Accessed Mar 10, 2021. (In Russ). https://democenter.nitrosbase.com/clinrecalg5/api.ashx?op= GetClinrecPdf&id=204_1
  4. Ashrafi GH, Salman NA. Pathogenesis of human papillomavirus — immunological responses to HPV infection. In: Human papillomavirus: Research in a global perspective. Ed. by Rajamanickam Rajkumar. InTech; 2016. https://doi.org/10.5772/63965
  5. Sterling JC, Gibbs S, Haque Hussain SS, MohdMustapa MF, Handfield-Jones SE. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.  https://doi.org/10.1111/bjd.13310
  6. Woodhall SC, Jit M, Soldan K, et al. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. SexTransmInfect. 2011;87(6):458-463.  https://doi.org/10.1136/sextrans-2011-050073
  7. Blomberg M, Friis S, Munk C, Bautz A, Kjaer SK. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts. J Infect Dis. 2012;205(10):1544-1553. https://doi.org/10.1093/infdis/jis228
  8. Abramovskikh OS, Telesheva LF, Letyaeva OI, Savochkina AYu, Orner IYu, Baturina IL, Mezentseva EA. Immunological aspects of pathogenesis of human papillomavirus infection in the female reproductive tract. Immunopatologiya, allergologiya, infektologiya. 2012;(2):95-101. Accessed Mar 10, 2021. (In Russ.). https://www.immunopathology.com/ru/article.php?carticle=497
  9. Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600-606.  https://doi.org/10.3892/ol.2015.3295
  10. Woodby B, Scott M, Bodily J. The Interaction Between Human Papillomaviruses and the Stromal Microenvironment. Prog Mol Biol Transl Sci. 2016; 144:169-238.  https://doi.org/10.1016/bs.pmbts.2016.09.003
  11. Nikonova AA, Pichugin AV, Chulkina MM, Lebedeva ES, Gaisina AR, Shilovsky IP, Ataullakhanov RI, Khaitov MR, Khaitov RM. Immunomax — a TLR4 agonist — affects the phenotype of pulmonary macrophages in respiratory syncytial viral infection in mice. Acta Naturae. 2018;10(4):87-94. Accessed Mar 10, 2021. (In Russ.). https://actanaturae.ru/2075-8251/article/view/10322/pdf
  12. Sokolova TM, Shuvalov AN, Shapoval IM, Sokolova ZA, Ershov FI. Activation of genes controlling the immune signaling pathways: differential individual sensitivity of human blood cells for interferon preparations and IFN inducers. Medical Immunology. 2015;17(1):7-18. (In Russ.). https://doi.org/10.15789/1563-0625-2015-1-7-18
  13. Ataullakhanov RI, Pichugin AV, Shishkova NM, Masternak TB, Malkina EYu, Ulyanova LI, Stetsenko ON. Cell mechanisms of the immunomodulating action produced by drug Immunomax. Immunologiya, 2005;26(2): 111-120. Accessed Mar 10, 2021. (In Russ.). https://studylib.ru/doc/2287242/kletochnye-mehanizmy-immunomoduliruyushhego-dejstviya
  14. Sokolovskiy EV, Ignatovskiy AV. Immunomodulating therapy of papillomavirus infection. Voprosy ginekologii, akusherstva i perinatologii. 2005;4(4): 27-30. Accessed Mar 10, 2021. (In Russ). https://www.elibrary.ru/contents.asp?id=33188898&;
  15. Perlamutrov YuN, Soloviev AM, Ataullakhanov RR, Olkhovskaya KB, Chernova NI. Application of antiviral immunity activator at complex therapy of relapsing sharpedging condilomas. Immunopatologiya, allergologiya, infektologiya. 2003;(3):138-141. Accessed Mar 10, 2021. (In Russ.). https://www.immunopathology.com/ru/article.php?carticle=361
  16. Rakhmatulina MR, Bolshenko NV, Kuevda DA, Trofimova OB. Particular features of the clinical course of the papilloma viral infection depending on quantitative indices of human papilloma viruses of a high carcinogenic. Vestnik dermatologii i venerologii. 2014;(3):95-105. Accessed Mar 10, 2021. (In Russ.). https://vestnikdv.ru/jour/article/view/38/39

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.